Skip to main content

Table 3 Correlations of functional and morphological properties of the arterial wall with clinical and laboratory parameters after PCSK9i treatment

From: Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors

Parameter

FMD

PWV

c-IMT

Age (years)

r = -0.3189; p = 0.061

r = -0.334; p = 0.001

r = -0.486; p < 0.0001

Body mass index (kg/m2)

r = -0.046; p = 0.435

r = 0.096; p = 0.365

r = 0.187; p = 0.142

Systolic blood pressure (mm Hg)

r = -0.286; p = 0.004

r = 0.566; p < 0.0001

r = 0.233; p = 0.021

Diastolic blood pressure (mm Hg)

r = -0.093; p = 0.361

r = 0.386; p < 0.0001

r = 0.097; p = 0.342

Total cholesterol (mmol/l)

r = -0.039; p = 0.701

r = -0.044; p = 0.454

r = -0.021; p = 0.834

HDL cholesterol (mmol/l)

r = 0.034; p = 0.738

r = 0.001; p = 0.996

r = 0.087; p = 0.339

LDL cholesterol (mmol/l)

r = 0-.036; p = 0.723

r = -0.096; p = 0.342

r = -0.01; p = 0.874

Triglycerides (mmol/l)

r = -0.071; p = 0.483

r = 0.061; p = 0.546

r = -0.013; p = 0.902

Lipoprotein (a) (mg/l)

r = 0.048; p = 0.638

r = 0.061; p = 0.550

r = -0.040; p = 0.697

Apolipoprotein B (g/l)

r = -0.060; p = 0.560

r = -0.066; p = 0.522

r = -0.039; p = 0.707

Apolipoprotein A1 (g/l)

r = 0.039; p = 0.705

r = -0.014; p = 0.895

r = 0.077; p = 0.454

hs-CRP (mg/l)

r = -0.107; p = 0.295

r = 0.145; p = 0.153

r = -0.038; p = 0.715

TNF-alpha (ng/l)

r = -0.035; p = 0.733

r = 0.096; p = 0.350

r = -0.029; p = 0.777

IL-6 (ng/l)

r = -0.124; p = 0.164

r = 0.062; p = 0.548

r = 0.109; p = 0.288

IL-8 (ng/l)

r = 0.131; p = 0.200

r = 0.058; p = 0.527

r = -0.015; p = 0.881

IL-10 (ng/l)

r = 0.026; p = 0.803

r = -0.045; p = 0.664

r = 0.152; p = 0.138

VCAM1 (mg/l)

r = -0.229; p = 0.024

r = -0.060; p = 0.559

r = -0.043; p = 0.677

TAFI (%)

r = 0.136; p = 0.194

r = 0.148; p = 0.157

r = -0.263; p = 0.011

PAI-1 (ng/ml)

r = -0.173; p = 0.122

r = 0.055; p = 0.627

r = 0.164; p = 0.146

OCP (Abs-sum)

r = -0.107 p = 0.296

r = 0.147 p = 0.150

r = 0.118 p = 0.251

OFP

r = -0.014 p = 0.893

r = -0.122; p = 0.235

r = -0.009; p = 0.929

OHP

r = -0.041; p = 0.687

r = 0.172; p = 0.091

r = 0.091; p = 0.378

  1. FMD flow mediated dilation, PWV pulse wave velocity, c-IMT carotid intima media thickness, HDL cholesterol high density lipoprotein cholesterol, LDL cholesterol low density lipoprotein cholesterol, hs-CRP high-sensitivity C reactive protein, TNF-alpha tumor necrosis factor alpha, IL-6 interleukin 6, IL-8 interleukin 8, IL-10 interleukin 10, VCAM1 vascular cell adhesion protein 1, TAFI thrombin activatable fibrinolysis inhibitor, PAI-1 plasminogen activator inhibitor 1, OCP overall coagulation potential, OFP overall fibrinolytic potential, OHP overall hemostasis potential